Baxter Receives Emergency OK for Kidney-Treatment Equipment
August 12 2020 - 9:46AM
Dow Jones News
By Matt Grossman
Baxter International Inc. has received emergency-use
authorizations from the Food and Drug Administration for equipment
used to treat acute kidney injury, a complication that can affect
Covid-19 patients, the company said Wednesday.
The authorizations are for two sets of devices used in
continuous renal replacement therapy, which mimics the function of
a healthy kidney by passing a patient's blood through a filter
outside of the body. The sets have been approved for use in
European countries for more than a decade, according to Baxter.
The approval will give hospitals greater flexibility in treating
patients, Baxter executive Reaz Rasul said.
One of the sets is designed for use in patients weighing less
than 20 kilograms, or about 44 pounds.
A limited supply of the devices will be available in the U.S. as
soon as possible, Baxter said, and production of more sets will
accelerate.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
August 12, 2020 09:31 ET (13:31 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Baxter (NYSE:BAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Baxter (NYSE:BAX)
Historical Stock Chart
From Apr 2023 to Apr 2024